News
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
BJD, 2023.Oras A. Alabas, Kayleigh J. Mason, Zenas Z.N. Yiu, Richard B. Warren, Nick Dand, Jonathan N.W.N. Barker, Catherine H. Smith, Christopher E.M. Grifï¬ths, the BADBIR and BSTOP study group.Read publication: BJD Related Contact Us...
Characteristics of “super responders” and “super nonresponders” to first biologic monotherapy for psoriasis: a nested case-control study
BJD, 2023.Kayleigh J. Mason, Oras A. Alabas, Nick Dand, Richard B. Warren, Nick J. Reynolds, Jonathan N.W.N. Barker, Zenas Z. N. Yiu, Catherine H. Smith, Christopher E.M. Griffiths, the BADBIR Study Group.Read publication: BJD Related ...
Password policy updates to the BADBIR Database
In our ongoing commitment to maintaining a secure and user-friendly online environment, we are updating our password policy. We kindly request all our users to consider reviewing and enhancing the strength of their passwords in preparation for the new criteria, which...
Centre of the month: October 2023
Imperial College Healthcare NHS Trust was selected for their hard work keeping on top of outstanding follow-ups. A message from Imperial College: We treat our patients as customers. We do not stop after they are recruited to the study or attending follow up. We...
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics
JID, 2023.Al-Janabi A, Eyre S, Foulkes AC, Khan AR, Dand N, Burova E, DeSilva B, Makrygeorgou, Davies E, Smith CH, Griffiths CEM, Morris AP, Warren RB; BSTOP & BADBIR Study Groups.Read publication: JID Related Contact Us Tel: +44 (0)161...
Recruitment to Kyntheum, Cimzia and Skilarence ending; Sotyktu registrations now accepted
Recruitment to Kyntheum (brodalumab), Cimzia (certolizumab pegol), and Skilarence (dimethyl fumarate) has now ended. Patients who were consented and started these treatments before the 1st August must be added to the database before 21st August. Recruitment is...
Centre of the month: July 2023
Nottingham University Hospitals NHS Trust was selected for getting up-to-date with their outstanding follow-ups. A message from Nottingham: BADBIR is a success at our site because of our valuable teamwork! Our teamwork is truly the confirmation of the dream work as...
Uptake of tumour necrosis factor – alpha inhibitor biosimilars for psoriasis: A drug utilisation study from BADBIR
BJD, 2023.Phan DB, Bewley AP, Smith CH, Mackenzie T, Griffiths CEM, Lunt M, Warren RB, Yiu ZZN; BADBIR Study Group.Read publication: BJD Related Contact Us Tel: +44 (0)161 306 1896 Email: badbir@manchester.ac.uk Find Us The University of...
Amendment 13
Study Amendment 13 to BADBIR has an implementation date of 06/03/2023. Documents in this amendment You can download all of the files for this amendment in one go using the link below (.zip file). If you would like the tracked changes versions of the documents to see...
Centre of the month: June 2023
Newcastle Upon Tyne Hospitals NHS Foundation Trust was selected for their successful recruitment and long term follow-up data collection. A message from Newcastle Upon Tyne: Our team's success is due to the research team being fully integrated within the psoriasis...
Contact Us
Find Us
The University of Manchester
First Floor Bright Building
Manchester Science Park
Manchester
M15 6GZ
